These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 19441906

  • 21. Design and synthesis of a fluorinated quinazoline-based type-II Trk inhibitor as a scaffold for PET radiotracer development.
    Bernard-Gauthier V, Mahringer A, Vesnaver M, Fricker G, Schirrmacher R.
    Bioorg Med Chem Lett; 2017 Jun 15; 27(12):2771-2775. PubMed ID: 28476569
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition.
    Bernard-Gauthier V, Schirrmacher R.
    Expert Opin Ther Pat; 2016 Jun 15; 26(2):291-5. PubMed ID: 26561352
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A chemical-genetic approach to studying neurotrophin signaling.
    Chen X, Ye H, Kuruvilla R, Ramanan N, Scangos KW, Zhang C, Johnson NM, England PM, Shokat KM, Ginty DD.
    Neuron; 2005 Apr 07; 46(1):13-21. PubMed ID: 15820690
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain.
    Duchemin AM, Ren Q, Mo L, Neff NH, Hadjiconstantinou M.
    J Neurochem; 2002 May 07; 81(4):696-707. PubMed ID: 12065629
    [Abstract] [Full Text] [Related]

  • 31. Trk receptor expression and inhibition in neuroblastomas.
    Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, Light JE, Kolla V, Evans AE.
    Clin Cancer Res; 2009 May 15; 15(10):3244-50. PubMed ID: 19417027
    [Abstract] [Full Text] [Related]

  • 32. Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers.
    Ghilardi JR, Freeman KT, Jimenez-Andrade JM, Mantyh WG, Bloom AP, Bouhana KS, Trollinger D, Winkler J, Lee P, Andrews SW, Kuskowski MA, Mantyh PW.
    Bone; 2011 Feb 15; 48(2):389-98. PubMed ID: 20854944
    [Abstract] [Full Text] [Related]

  • 33. Expression of Trk receptors in otolith-related neurons in the vestibular nucleus of rats.
    Zhang FX, Lai CH, Tse YC, Shum DK, Chan YS.
    Brain Res; 2005 Nov 16; 1062(1-2):92-100. PubMed ID: 16256078
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Loxo TRK inhibitor data wows oncologists.
    Dolgin E.
    Nat Biotechnol; 2017 Aug 08; 35(8):694-695. PubMed ID: 28787403
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Trk receptor tyrosine kinases: a bridge between cancer and neural development.
    Nakagawara A.
    Cancer Lett; 2001 Aug 28; 169(2):107-14. PubMed ID: 11431098
    [Abstract] [Full Text] [Related]

  • 39. Dimerization of the Trk receptors in the plasma membrane: effects of their cognate ligands.
    Ahmed F, Hristova K.
    Biochem J; 2018 Nov 30; 475(22):3669-3685. PubMed ID: 30366959
    [Abstract] [Full Text] [Related]

  • 40. Protein tyrosine phosphatase receptor type Z dephosphorylates TrkA receptors and attenuates NGF-dependent neurite outgrowth of PC12 cells.
    Shintani T, Noda M.
    J Biochem; 2008 Aug 30; 144(2):259-66. PubMed ID: 18477627
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.